Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality-Reference-Cited by-同舟云学术

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

Published:2021-11-26 Issue:48 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Brunet-Ratnasingham Elsa¹²^ORCID,Anand Sai Priya¹³,Gantner Pierre¹²,Dyachenko Alina¹^ORCID,Moquin-Beaudry Gaël¹⁴^ORCID,Brassard Nathalie¹,Beaudoin-Bussières Guillaume¹²,Pagliuzza Amélie¹^ORCID,Gasser Romain¹^ORCID,Benlarbi Mehdi¹^ORCID,Point Floriane¹^ORCID,Prévost Jérémie¹²,Laumaea Annemarie¹,Niessl Julia¹²^ORCID,Nayrac Manon¹²,Sannier Gérémy¹²^ORCID,Orban Catherine²⁵,Messier-Peet Marc¹⁵,Butler-Laporte Guillaume⁶⁷^ORCID,Morrison David R.⁶^ORCID,Zhou Sirui⁶⁷^ORCID,Nakanishi Tomoko⁶⁸⁹¹⁰^ORCID,Boutin Marianne¹²,Descôteaux-Dinelle Jade¹²,Gendron-Lepage Gabrielle¹^ORCID,Goyette Guillaume¹^ORCID,Bourassa Catherine¹^ORCID,Medjahed Halima¹,Laurent Laetitia⁶,Rébillard Rose-Marie¹⁴^ORCID,Richard Jonathan¹²,Dubé Mathieu¹,Fromentin Rémi¹^ORCID,Arbour Nathalie¹⁴^ORCID,Prat Alexandre¹⁴^ORCID,Larochelle Catherine¹⁴^ORCID,Durand Madeleine¹⁵^ORCID,Richards J. Brent⁶⁷⁸¹¹,Chassé Michaël¹⁵^ORCID,Tétreault Martine¹⁴,Chomont Nicolas¹²^ORCID,Finzi Andrés¹²³^ORCID,Kaufmann Daniel E.¹²⁵¹²^ORCID

Affiliation:

1. Research Centre of the Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada.

2. Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, QC, Canada.

3. Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.

4. Department of Neuroscience, Université de Montréal, Montréal, QC, Canada.

5. Centre hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada.

6. Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, QC, Canada.

7. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.

8. Department of Human Genetics, McGill University, Montreal, QC, Canada.

9. Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

10. Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, 102-0083 Tokyo, Japan.

11. Department of Twin Research, King’s College London, London, UK.

12. Département de Médecine, Université de Montréal, Montréal, QC, Canada.

Abstract

Statistical models of plasma immunovirological features validate SARS-CoV-2 vRNA as an early predictor of COVID-19 mortality.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference66 articles.

1. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

2. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

3. Dexamethasone in Hospitalized Patients with Covid-19

4. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

5. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): Preliminary results of a randomised, controlled, open-label, platform trial;RECOVERY Collaborative Group;medRxiv,2021

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. Deciphering Fc-effector functions against SARS-CoV-2;Trends in Microbiology;2024-08

3. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity;Nature Communications;2024-05-16

4. Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination;2024-02-29

5. Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV;iScience;2024-01